Difference between revisions of "Team:Marburg/Human Practices"

Line 481: Line 481:
 
           <div class="sub-header">
 
           <div class="sub-header">
 
             <h1>
 
             <h1>
               N I N A<br>
+
               D R . &ensp;N I N A<br>
 
               S C H E E R
 
               S C H E E R
 
             </h1>
 
             </h1>
Line 495: Line 495:
 
           <div class="popup-container">
 
           <div class="popup-container">
 
             <div class="popup-header">
 
             <div class="popup-header">
               <h1 class="title">Nina Scheer</h1>
+
               <h1 class="title">Dr. Nina Scheer</h1>
 
               <button type="button" onclick="hide('nina_scheer')">X</button>
 
               <button type="button" onclick="hide('nina_scheer')">X</button>
 
             </div>
 
             </div>
Line 512: Line 512:
 
                   preventing any further development and leaving important key technologies to global competitors.<br>
 
                   preventing any further development and leaving important key technologies to global competitors.<br>
 
                   <br>
 
                   <br>
                   As we told Scheer about our project she was convinced of our good spirit and supported the idea that
+
                   As we discussed with Dr. Scheer about our project and green genetical engineering in general, she supported the idea that
                   the state should put more money into research, rather than us relying on third-party funds.
+
                   the state should invest more funding into research, rather than us relying on third-party funds.
                   Nonetheless did Scheer see a trust issue concerning irreversible damages to nature and humankind as
+
                   Nonetheless, Dr. Scheer did see a trust issue concerning irreversible damages to nature and humankind as
 
                   well as a lack of good control mechanisms when using green genetic engineering. At the example of
 
                   well as a lack of good control mechanisms when using green genetic engineering. At the example of
                   Contergan® Scheer highlighted the challenges of uncertainty. We learned that we as scientists have
+
                   Contergan® Nina Scheer highlighted the challenges of uncertainty. We learned that we as scientists have
 
                   the duty to proof the unmitigated safety of our products and beyond that not only proof it to our
 
                   the duty to proof the unmitigated safety of our products and beyond that not only proof it to our
 
                   own community but also to bring this trust to society as a whole if we want our research to have an
 
                   own community but also to bring this trust to society as a whole if we want our research to have an
 
                   impact on reality.<br>
 
                   impact on reality.<br>
 
                   <br>
 
                   <br>
                   We thank Nina Scheer for this opportunity to discuss major issues of our time.<br>
+
                   We thank Dr. Nina Scheer for this opportunity to discuss major issues of our time.<br>
 
                 </p>
 
                 </p>
 
               </section>
 
               </section>

Revision as of 12:23, 7 December 2019

H U M A N   P R A C T I C E S


Report on Genetic Engineering

Genetic engineering has been a hotly debated topic in politics as well as society in the past decades and still is today. Arguments like the nutrition of a growing world population due to a declining infant mortality rate or the loss of considerable areas of arable land due to erosion or pollution damage keep fueling the controversy whether genetically modified organisms (GMO), especially crops, are needed to sustain the global demand for food. On the opposite, concerns have been raised concerning the potential adverse effects on human health and environmental safety. Besides the facts, part of the public dispute is based around ethical questions and trust issues towards institutions and authorities. There have been studies and surveys carried out addressing many of these topics. Additionally a diverse cluster of organisations and the media is bombarding the public with contrary statements. This report tries to give an overview on mankind's relation towards modifying genetics, a brief summary of used methods, and gathers statements from scientists and authorities. It is meant as the motivational basis for this years Marburg iGEM team´s Public Engagement and Human Practice efforts.


G M O
R E P O R T


Gathering reviews, opinions and statements, this report is meant as the foundation of our Human Practice efforts.

D R .  N I N A
S C H E E R


Policy makers are caught between public concerns and expert opinions. Communication is key.

P L A N T   M A R K E T


Reaching out to senior people, we advertised our panel discussion and adressed public concerns towards genetically modified organims.

P A N E L D I S C U S S I O N


The panel discussion allowed regional residents to debate with experts from various fields about green genetic engineering.

Integrated Human Practices

C Y A N O
B I O T E C H


Influencing our project on many levels: growth curves, terminators and well plate cultivation.

P R O F.   D R.
A N N E G R E T   W I L D E


Cultivation expertise from leading cyano scientist Prof. Wilde.

D O U L I X


Confirmation for real case use for our colony picking project.

S T A N D A R D I Z A T I O N


Realizing that we are not the only ones struggeling with no cyano research standarization...

C Y A N O
C O N F E R E N C E   2 0 1 9


Knowledge exchange with established cyanobacteria researchers.

E X P E R T   O N   C Y A N O S :
J A M E S   G O L D E N


Defining the absent standardization to discrepancies in light, optical denisty measurement and more.

E X P E R T   O N   C Y A N O S:
N I C O L A S  S C H M E L L I N G


And soon, we could add growth media to the growing list of not existing standardization.

O P E N T R O N S
+   K E O N I


Initial inspirations for our colony picking project.

P R O M E G A


Automation of plasmid purification using the OT-2.